Filing Details

Accession Number:
0001179110-20-007740
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-23 20:42:15
Reporting Period:
2020-06-21
Accepted Time:
2020-06-23 20:42:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1711968 Leonard Steven Chapman C/O Natera, Inc., 201 Industrial Road
Suite 410
San Carlos CA 94070
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-21 1,117 $0.00 26,415 No 4 M Direct
Common Stock Acquisiton 2020-06-22 181 $0.00 26,596 No 4 M Direct
Common Stock Acquisiton 2020-06-22 3,125 $0.00 29,721 No 4 M Direct
Common Stock Disposition 2020-06-22 558 $46.47 29,163 No 4 S Direct
Common Stock Acquisiton 2020-06-22 31,250 $13.01 60,413 No 4 M Direct
Common Stock Disposition 2020-06-22 4,753 $43.89 55,660 No 4 S Direct
Common Stock Disposition 2020-06-22 28,496 $45.07 27,164 No 4 S Direct
Common Stock Disposition 2020-06-22 5,547 $46.04 21,617 No 4 S Direct
Common Stock Disposition 2020-06-23 92 $45.51 21,525 No 4 S Direct
Common Stock Disposition 2020-06-23 1,579 $45.51 19,946 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2020-06-21 1,117 $0.00 1,117 $0.00
Common Stock Restricted Stock Unit Disposition 2020-06-22 181 $0.00 181 $0.00
Common Stock Restricted Stock Unit Disposition 2020-06-22 3,125 $0.00 3,125 $0.00
Common Stock Stock Option (right to buy) Disposition 2020-06-22 31,250 $0.00 31,250 $13.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,352 No 4 M Direct
2,002 No 4 M Direct
34,375 No 4 M Direct
131,250 2020-01-10 No 4 M Direct
Footnotes
  1. Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting March 21, 2018.
  2. Each RSU represents a contingent right to receive one share of the common stock of the issuer.
  3. Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting March 22, 2020.
  4. The sale of shares was effected in order to satisfy tax liabilities due at the time of vesting.
  5. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020.
  6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.38 to $44.38 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.485 to $45.45 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.59 to $46.47 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  9. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.51 to $45.6274 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  10. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.51 to $45.5275 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  11. The RSUs vest over four years. 25% of the RSUs vest on March 21, 2018 and the remaining shares vest in 12 equal quarterly installments thereafter.
  12. The RSUs vest over four years. 25% of the RSUs vest on March 22, 2020 and the remaining shares vest in 12 equal quarterly installments thereafter.
  13. This option becomes exercisable, if at all, upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. The first milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $2,000,000,000 and (ii) the Issuer's outstanding shares as most recently reported on the Issuer's Form 10-Q or Form 10-K (the "Capitalization"). The second milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $3,000,000,000 and (ii) the Capitalization (the "Performance Vesting Conditions"). As of June 8, 2020, the Company's Board of Director determined the performance criteria had been met with respect to 62,500 additional shares.